Uras G

References (4)

Title : Development of p-Tau Differentiated Cell Model of Alzheimer's Disease to Screen Novel Acetylcholinesterase Inhibitors - Uras_2022_Int.J.Mol.Sci_23_
Author(s) : Uras G , Li X , Manca A , Pantaleo A , Bo M , Xu J , Allen S , Zhu Z
Ref : Int J Mol Sci , 23 : , 2022
PubMedID: 36499118

Title : Novel inhibitors of AChE and Abeta aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease - Liu_2022_Eur.J.Med.Chem_235_114305
Author(s) : Liu Y , Uras G , Onuwaje I , Li W , Yao H , Xu S , Li X , Phillips J , Allen S , Gong Q , Zhang H , Zhu Z , Liu J , Xu J
Ref : Eur Journal of Medicinal Chemistry , 235 :114305 , 2022
PubMedID: 35339839

Title : In vivo Evaluation of a Newly Synthesized Acetylcholinesterase Inhibitor in a Transgenic Drosophila Model of Alzheimer's Disease - Uras_2021_Front.Neurosci_15_691222
Author(s) : Uras G , Manca A , Zhang P , Markus Z , Mack N , Allen S , Bo M , Xu S , Xu J , Georgiou M , Zhu Z
Ref : Front Neurosci , 15 :691222 , 2021
PubMedID: 34276297

Title : Discovery of Novel Tacrine-Pyrimidone Hybrids as Potent Dual AChE\/GSK-3 Inhibitors for the Treatment of Alzheimer's Disease - Yao_2021_J.Med.Chem__
Author(s) : Yao H , Uras G , Zhang P , Xu S , Yin Y , Liu J , Qin S , Li X , Allen S , Bai R , Gong Q , Zhang H , Zhu Z , Xu J
Ref : Journal of Medicinal Chemistry , : , 2021
PubMedID: 34024109